Document is current

Any future updates will be listed below

High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment

Crossref DOI link: https://doi.org/10.1186/s12885-015-1840-6

Published Online: 2015-11-02

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark